ALEMBIC PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 994.6 INR | -0.50% |
|
+5.79% | +30.98% |
Chart calendar Alembic Pharmaceuticals Limited
8d40340e7a9eaaba5436d278.t2P159UZY6kxe2PTt6_UzuKxZGTCYZFSTAubuhJSo-o.4VuzjrBYDPlkDi-xxPa1i7r3ATS7U_4hHW6rz2gAkNr5AL6yl29Qw3UUCA~20c553f9061a2be6697bd2561b912e81
Upcoming events on Alembic Pharmaceuticals Limited
Past events on Alembic Pharmaceuticals Limited
| 19/02/2024 | Kotak Chasing Growth Conference |
| 05/02/2024 04:30 pm | Q3 2024 Earnings Call |
| 05/02/2024 02:17 pm | Q3 2024 Earnings Release |
| 07/11/2023 05:00 pm | Q2 2024 Earnings Call |
| 07/11/2023 01:45 pm | Q2 2024 Earnings Release |
| 21/08/2023 | Roadshow - Prabhudas Lilladher Private Limited |
| 11/08/2023 | Investec Healthcare & Chemicals Conference |
| 04/08/2023 05:00 pm | Q1 2024 Earnings Call |
| 04/08/2023 03:00 pm | Annual General Meeting |
| 04/08/2023 01:38 pm | Q1 2024 Earnings Release |
| 28/07/2023 | Ex-dividend day for final dividend |
| 01/06/2023 | Trinity India Investor Conference |
| 05/05/2023 05:30 pm | Q4 2023 Earnings Call |
| 05/05/2023 | Q4 2023 Earnings Release |
| 20/02/2023 | Kotak Chasing Growth Conference |
| 01/02/2023 06:38 pm | Q3 2023 Earnings Release |
| 01/02/2023 05:00 pm | Q3 2023 Earnings Call |
| 25/11/2022 | Investor Meeting - Nirmal Bang Institutional Equities |
| 11/11/2022 05:30 pm | Interim 2023 Earnings Call |
| 11/11/2022 03:00 pm | Annual General Meeting |
Past dividends on Alembic Pharmaceuticals Limited
| 28/07/2023 | Annual 8 INR |
| 17/08/2022 | Interim Payment 10 INR |
| 19/07/2021 | Annual 14 INR |
| 16/03/2020 | Interim Payment 7 INR |
| 16/03/2020 | Bonus Payment 3 INR |
| 18/07/2019 | Annual 5.5 INR |
| 18/07/2018 | Annual 4 INR |
| 11/07/2017 | Annual 4 INR |
| 20/07/2016 | Annual 4 INR |
| 22/07/2015 | Annual 3.5 INR |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 39 347 39 805 -1.15% | 46 058 45 153 2% | 53 931 54 155 -0.41% | 53 058 51 746 2.54% | 56 526 56 275 0.45% | 63 378 |
|
EBITDA Million INR | Released Forecast Spread | 8 736 8 894 -1.78% | 12 230 11 246 8.75% | 15 576 15 651 -0.48% | 8 742 10 106 -13.5% | 7 084 7 614 -6.96% | 9 345 |
|
EBIT Million INR | Released Forecast Spread | 7 584 7 648 -0.85% | 10 657 10 253 3.94% | 13 741 13 890 -1.07% | 5 874 7 805 -24.74% | 4 329 5 042 -14.14% | 6 581 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 7 493 7 660 -2.18% | 9 998 9 510 5.13% | 13 681 13 760 -0.58% | 6 201 8 011 -22.59% | 3 855 4 004 -3.73% | 6 242 |
|
Net income Million INR | Released Forecast Spread | 5 844 5 885 -0.71% | 8 291 7 590 9.24% | 11 781 11 559 1.92% | 5 457 6 836 -20.18% | 3 420 3 007 13.74% | 5 917 |
|
EPS INR | Released Forecast Spread | 31,0 31,3 -0.93% | 44,0 39,9 10.22% | 60,8 59,1 2.87% | 27,8 34,8 -20.13% | 17,4 15,6 11.63% | 30,2 |
| Announcement Date | 08/05/19 | 23/04/20 | 04/05/21 | 02/05/22 | 05/05/23 | - |
Quarterly results
| Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 12 804 12 793 0.09% | 13 260 12 963 2.29% | 12 923 13 261 -2.55% | 12 717 12 733 -0.13% | 14 157 12 444 13.77% | 12 621 13 884 -9.09% | 14 750 14 011 5.27% | 15 090 14 483 4.19% | 14 065 13 962 0.73% | 14 862 18 189 -18.29% | 15 448 | 16 275 | 16 060 |
|
EBITDA Million INR | Released Forecast Spread | 3 417 3 255 4.98% | 2 359 3 444 -31.5% | 2 572 2 511 2.46% | 2 557 2 508 1.95% | 1 601 2 390 -33% | 147 2 604 -94.37% | 2 327 2 082 11.78% | 2 488 2 421 2.73% | 2 122 2 046 3.73% | 1 987 2 384 -16.65% | 2 452 | 2 444 | 2 606 |
|
EBIT Million INR | Released Forecast Spread | 1 997 1 817 9.92% | 370 1 904 -80.56% | 1 650 1 247 32.35% | 1 823 1 574 15.79% | 1 381 1 421 -2.81% | 1 536 | 1 706 | ||||||
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 2 919 3 026 -3.55% | 1 826 2 620 -30.32% | 2 002 1 938 3.35% | 1 967 1 868 5.34% | 406 1 861 -78.19% | -602 2 131 -128.23% | 1 530 1 166 31.18% | 1 681 1 454 15.61% | 1 246 1 293 -3.62% | 1 298 2 348 -44.72% | 1 587 | 1 680 | 1 695 |
|
Net income Million INR | Released Forecast Spread | 2 507 2 304 8.82% | 1 645 2 453 -32.94% | 1 693 1 678 0.87% | 1 764 1 593 10.73% | 355 1 539 -76.96% | -659 1 680 -139.21% | 1 334 1 150 15.97% | 1 219 1 308 -6.81% | 1 526 998 52.85% | 1 206 1 283 -5.98% | 1 470 | 1 413 | 1 467 |
|
EPS INR | Released Forecast Spread | 12,8 11,2 13.84% | 8,37 9,00 -7% | 8,61 8,40 2.5% | 8,98 7,90 13.67% | 1,80 7,58 -76.24% | 6,78 7,00 -3.14% | 6,20 | 5,25 | 6,00 | ||||
| Announcement Date | 04/05/21 | 26/07/21 | 10/11/21 | 10/02/22 | 02/05/22 | 04/08/22 | 11/11/22 | 01/02/23 | 05/05/23 | 04/08/23 | - | - | - |
More events
Past sector events for Alembic Pharmaceuticals Limited
| Today 05:00 pm | ORGANON & CO.: Q1 2024 Earnings Release |
| Today 11:00 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| Today | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| Today | AMGEN INC.: Q1 2024 Earnings Release |
| 02/05/2024 01:35 am | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 02/05/2024 01:35 am | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 01/05/2024 04:15 pm | PFIZER, INC.: Q1 2024 Earnings Release |
| 01/05/2024 12:30 pm | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 01/05/2024 11:30 am | GSK PLC: Q1 2024 Earnings Release |
| 01/05/2024 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APLLTD Stock
- Calendar Alembic Pharmaceuticals Limited
